MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.infpip.2026.100578

Медицинская библиотека · Infection prevention in practice · 2026

Pharmacist-coordinated IDST treatment bundle achievement and impact on mortality in MRSA bacteraemia: a single-centre retrospective cohort study.

Endo Aiju, Hanai Yuki, Mikawa Takahiro, Asakawa Daiki, Ishibe Taiki, Nakane Yu, Tanaka Misako, Mitsui Daichi, Kido Shinji, Nonaka Takeshi, Fujimori Ken, Kudo Nozomi, Nakadoi Yuta, Kobayashi Yukimasa, Negishi Rintaro, Fujimori Ayaka, Takatori Mika, Natsume Yasuyuki, Matsumoto Kaori, Matsumoto Kazuaki

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia carries high mortality. At Yamanashi Prefectural Central Hospital, antimicrobial stewardship has focused on appropriate drug use. In 2022, a pharmacist-coordinated Infectious Disease Support Team (IDST) was established to optimize management, including diagnostics, dosing, and treatment duration. We evaluated the effects of IDST participation on the adherence to a predefined Staphylococcus aureus bacteraemia treatment bundle and mortality.

METHODS

We conducted a single-centre retrospective cohort study of adults with MRSA bacteraemia diagnosed between April 2020 and June 2025. Patients were categorized into IDST intervention or non-intervention groups. Bundle adherence (≥ 75% defined as ≥ 9/12 items) and 28- and 90-day mortality were analysed using Kaplan-Meier analysis with log-rank tests and Cox proportional-hazards models; two-sided P < 0.05 was considered significant.

RESULTS

Eighty-five patients were included in the present study. Overall, bundle adherence ≥75% occurred in 57.6%; adherence was higher with IDST than without (79.5% vs 39.1%); 28-day mortality occurred in 26 (30.6%) and 90-day mortality in 42 (49.4%), respectively. Survival analysis showed lower 28-day (log-rank P=0.031) and 90-day mortality (P=0.017) with IDST. In multi-variable models, IDST remained independently protective at 28 days (hazard ratio [HR] 0.328, 95% CI: 0.136-0.792; P=0.013) and 90 days (HR 0.427, 95% CI: 0.215-0.846; P=0.015).

CONCLUSIONS

Pharmacist-coordinated IDST co-management significantly improved adherence to evidence-based care and was associated with reduced short- and intermediate-term mortality in patients with MRSA bacteraemia. This model may be applicable to hospitals with limited continuous on-site availability of infectious disease physicians, provided that specialist oversight remains accessible.

Для цитирования: Endo Aiju, Hanai Yuki, Mikawa Takahiro, Asakawa Daiki, Ishibe Taiki, Nakane Yu, Tanaka Misako, Mitsui Daichi, Kido Shinji, Nonaka Takeshi, Fujimori Ken, Kudo Nozomi, Nakadoi Yuta, Kobayashi Yukimasa, Negishi Rintaro, Fujimori Ayaka, Takatori Mika, Natsume Yasuyuki, Matsumoto Kaori, Matsumoto Kazuaki. Pharmacist-coordinated IDST treatment bundle achievement and impact on mortality in MRSA bacteraemia: a single-centre retrospective cohort study.. Infection prevention in practice. 2026. DOI: 10.1016/j.infpip.2026.100578.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.